The most trusted name in at-home ketamine therapy

Mindbloom Tablets combine clinical precision, compassionate care, and proven results through flexible, guided treatment built for everyday life.

Am I a candidate?

Progress you can feel, healing you can trust.

Safety information
Important Safety Information

Mindbloom pairs individuals with licensed clinicians who are trained to diagnose and treat anxiety, depression, and other mental health conditions.  If one of the licensed clinicians, in their medical judgment, decides that ketamine is an appropriate treatment for an individual based on a clinical assessment, then the clinician may prescribe ketamine tablets that are compounded by pharmacies under Section 503A of the federal Food, Drug, and Cosmetic Act (FDCA).  Drugs compounded under Section 503A do not require FDA approval, and as such the FDA has not determined that the compounded ketamine prescribed is safe and effective for anxiety, depression, or other mental health conditions.  The use of ketamine for anxiety, depression, and many other mental health conditions, however, is supported by a body of scientific literature.  (Data on file).

Ketamine is a Schedule III controlled substance. Other drugs containing ketamine, which (unlike compounded drugs) are subject to FDA’s approval requirements, have been FDA-approved as an intravenous or intramuscular injection solution for induction and maintenance of general anesthesia. However, those drugs have not been FDA-approved for anxiety, depression, or other mental health conditions, and they have not been FDA-approved in tablet form. The approved label is available here.

Ketamine may cause serious side effects, including but not limited to risks of: sedation; dissociation; psychiatric events or worsening of psychiatric disorders, including problems in people with schizophrenia, severe personality disorders, or other serious mental disorders; dependence, abuse and misuse; anxiety; increases in blood pressure or heart rate; respiratory depression (breathing becomes slower and shallower and the lungs fail to exchange carbon dioxide and oxygen efficiently); lower urinary tract and bladder symptoms, including frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size; altered sense of time; dry mouth; elevated intraocular or intracranial pressure; loss of appetite; confusion; nausea/vomiting; blurred vision; and slurred speech.

The FDA has advised that at-home administration of compounded ketamine may present additional risks because a health care provider is not available onsite to monitor for adverse outcomes resulting from sedation and dissociation.

Mindbloom’s protocols and guidance have been designed to minimize the likelihood of experiencing these side effects or other adverse effects, and should be followed carefully. Ketamine should only be taken as directed by the treating clinician.

Do not proceed with ketamine treatment if any of the following apply to you:

  • Allergic to ketamine
  • Symptoms of psychosis or mania
  • Uncontrolled high blood pressure
  • CHF or other serious heart problem
  • Severe breathing problem
  • History of elevated intraocular or intracranial pressure
  • History of hyperthyroidism
  • Other serious medical illness
  • Pregnant, nursing, or trying to become pregnant

Ketamine has been found to cause moderate psychological dependency in some users.

  • In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
  • Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders
  • Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your clinician before proceeding with treatment
  • The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents

To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:

  • Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
  • Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
  • Continue to take antihypertensive medication as prescribed
  • Do not take ketamine while hungover or with alcoholic beverages
  • Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
  • Ketamine treatment should never be conducted without a peer treatment monitor physically present

A peer-reviewed study of Mindbloom’s client treatment outcomes was published in the Journal of Affective Disorders in 2022, titled At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial. The FDA has not evaluated head-to-head trials comparing the safety of ketamine to other medications that are FDA-approved for the treatment of depression, anxiety, or other psychiatric disorders. Although some clients report that they had more success with ketamine than with FDA-approved therapies, these outcomes may not be typical.

For more information about the informed consent that clients review and sign prior to treatment, please visit mindbloom.com/informed-consent.

Outcomes backed by data, not promises

The only at-home ketamine therapy backed by peer-reviewed outcomes. Real data, real clients, real healing. Results you can trust because they’ve been studied, measured, and proven.

Comprehensive care that goes beyond medicine

You’ll receive ongoing integration support, personalized guidance, and structured programs that help your insights turn into lasting change.

Guided treatment from the comfort of your home

Frustration-free ketamine therapy on your schedule, in your space. No traffic, no in-office appointments.

Am I a candidate?
Safety information
Important Safety Information

Mindbloom pairs individuals with licensed clinicians who are trained to diagnose and treat anxiety, depression, and other mental health conditions.  If one of the licensed clinicians, in their medical judgment, decides that ketamine is an appropriate treatment for an individual based on a clinical assessment, then the clinician may prescribe ketamine tablets that are compounded by pharmacies under Section 503A of the federal Food, Drug, and Cosmetic Act (FDCA).  Drugs compounded under Section 503A do not require FDA approval, and as such the FDA has not determined that the compounded ketamine prescribed is safe and effective for anxiety, depression, or other mental health conditions.  The use of ketamine for anxiety, depression, and many other mental health conditions, however, is supported by a body of scientific literature.  (Data on file).

Ketamine is a Schedule III controlled substance. Other drugs containing ketamine, which (unlike compounded drugs) are subject to FDA’s approval requirements, have been FDA-approved as an intravenous or intramuscular injection solution for induction and maintenance of general anesthesia. However, those drugs have not been FDA-approved for anxiety, depression, or other mental health conditions, and they have not been FDA-approved in tablet form. The approved label is available here.

Ketamine may cause serious side effects, including but not limited to risks of: sedation; dissociation; psychiatric events or worsening of psychiatric disorders, including problems in people with schizophrenia, severe personality disorders, or other serious mental disorders; dependence, abuse and misuse; anxiety; increases in blood pressure or heart rate; respiratory depression (breathing becomes slower and shallower and the lungs fail to exchange carbon dioxide and oxygen efficiently); lower urinary tract and bladder symptoms, including frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size; altered sense of time; dry mouth; elevated intraocular or intracranial pressure; loss of appetite; confusion; nausea/vomiting; blurred vision; and slurred speech.

The FDA has advised that at-home administration of compounded ketamine may present additional risks because a health care provider is not available onsite to monitor for adverse outcomes resulting from sedation and dissociation.

Mindbloom’s protocols and guidance have been designed to minimize the likelihood of experiencing these side effects or other adverse effects, and should be followed carefully. Ketamine should only be taken as directed by the treating clinician.

Do not proceed with ketamine treatment if any of the following apply to you:

  • Allergic to ketamine
  • Symptoms of psychosis or mania
  • Uncontrolled high blood pressure
  • CHF or other serious heart problem
  • Severe breathing problem
  • History of elevated intraocular or intracranial pressure
  • History of hyperthyroidism
  • Other serious medical illness
  • Pregnant, nursing, or trying to become pregnant

Ketamine has been found to cause moderate psychological dependency in some users.

  • In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
  • Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders
  • Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your clinician before proceeding with treatment
  • The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents

To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:

  • Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
  • Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
  • Continue to take antihypertensive medication as prescribed
  • Do not take ketamine while hungover or with alcoholic beverages
  • Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
  • Ketamine treatment should never be conducted without a peer treatment monitor physically present

A peer-reviewed study of Mindbloom’s client treatment outcomes was published in the Journal of Affective Disorders in 2022, titled At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial. The FDA has not evaluated head-to-head trials comparing the safety of ketamine to other medications that are FDA-approved for the treatment of depression, anxiety, or other psychiatric disorders. Although some clients report that they had more success with ketamine than with FDA-approved therapies, these outcomes may not be typical.

For more information about the informed consent that clients review and sign prior to treatment, please visit mindbloom.com/informed-consent.

Injectables
Tablets

Mindbloom Tablets

Sublingual ketamine treatment

$209/session for 6 sessions

Get started

We do our research so you can do your research.

Mindbloom’s best in class outcomes were validated in the two largest-ever peer-reviewed studies on psychedelic medicine.

Study co-authors from:
89%

reported improvement in their depression and anxiety symptoms1

95%

reported no side effects1

84%

who experienced significant improvements maintained progress or recovered with a second round of treatment2

GET POWERFUL RESULTS, RIGHT AT HOME

Other at-home programs deliver tablets. Mindbloom delivers transformation. 


Our approach combines medicine with meaning—pairing personalized dosing, expert oversight, and guided integration to make every experience safe, supported, and effective.

Am I a candidate?

The premium experience you can only get with Mindbloom.

See what sets us apart from the average IV clinic.

Joyous
Clinical efficacy

Back by the two largest peer-reviewed studies of ketamine therapy

No peer-reviewed outcomes data published

Safety & side effects

95% report no side effects, peer-reviewed

No peer-reviewed safety data published

Treatment protocol

Personalized dosing and flexible session schedule

Low-dose daily

Guidance & coaching

1:1 personal coaching and integration support

Curated psychology-based courses

Access to care

Available in 38 states

Available in 28 states

Transformation tools

Intention setting, soundscapes, voice journaling, and more

None

Community

Empowering client community with daily group circles

Not included

Insurance coverage

Partial out-of-network reimbursement for eligible plans; HSA and FSA accepted

100% self-pay, HSA and FSA accepted

Mindbloom changes lives. But don’t take our word for it.

Hear moving and mindful stories of personal transformation.*

Ketamine therapy introduced Jenn to a new way of seeing herself.

Paid Partner

Joy, happiness, confidence. Everything shifted for Peter.

Follow along with Brandi on the day of her Mindbloom session.

Paid Partner

Marissa’s mental reset and bounce back from social anxiety.

Paid Partner

How Hannah navigates her grief with Mindbloom therapy.

Paid Partner

Katie immediately felt lighter and planted in the present moment.

Jesse’s goal is to reprogram deep rooted triggers of his anxiety.

Paid Partner

The level of support Danny felt blew her mind.

Paid Partner

For Seth, everything changed. In the best way.

Shannon became the author of her life and got to create her own narrative.

Paid Partner

Kyle found a sense of connectedness and compassion.

Kayleigh’s family has the best version of her back.

Brie’s heartwarming journey to self-love.

Stephanie saw benefits almost immediately and for weeks to come.

Laura turned to Mindbloom after a tragic loss.

Barbara’s world went from black and white to technicolor.

In Daniel’s words: It works. It actually works!

Paid Partner

Patsy’s experiences showed her things she didn’t know she needed to see.

For Jules, talk therapy didn’t provide the tools she needed to heal her depression.

Paid Partner

Jon gained a deeper understanding of trauma and how to acknowledge it.

Paid Partner

Intentions are key. Han knows what you get out is what you put in.

Paid Partner

Casey was able to reconnect with his wife and his emotional self.

*Opinions expressed belong to the individuals depicted. Results may vary and may not be representative of all clients. Individuals marked Paid Partner were compensated to share their experience.

FAQ

How are ketamine tablets different from IV ketamine infusions?

Both can be effective, with some key differences:⁴³'⁴⁸'⁵⁶

Sublingual tablets:

• 
At-home administration, no needles
• Effects onset in 10-15 minutes, build gradually~30% bioavailability
• 60% more affordable than IV clinics
• Held in the mouth for 7 minutes before being spit out
• More variable absorption between individuals


IV ketamine:

• Requires clinic visit and IV access
• Effects onset in 1-2 minutes, more intense
• 100% bioavailability (direct bloodstream)
• More expensive ($400-800 per session)
• More consistent dosing, requires in-person monitoring
• Clinical research shows both routes produce meaningful improvements—the choice often depends on individual preferences, access, and response.⁵'⁴³'⁵⁶


Here are some additional considerations for ketamine tablets:⁹

Variable absorption: Some people report inconsistent session intensity. This can result from differences in individual bioavailability, technique (holding tablets for the full 7 minutes), oral tissue health, or accidentally swallowing medication.⁸'⁴⁴

Taste: Some find the taste unpleasant, though most adapt over the course of treatment.⁹

Technique requirements: Proper administration requires following instructions carefully—holding tablets in the right place for the full 7 minutes without swallowing.⁹

How do I know whether Tablets or Injectables are right for me?

This decision is made during your first Video Consult, where you discuss your specific needs with a clinician. They'll help you understand which option might work best based on your history and treatment goals.

With clinician approval, you are able to switch between Tablets and Injectables at the beginning of a 6 treatment prescription. When you meet with your clinician for a follow-up consult to get a new shipment of medication, we suggest discussing options to find the best route for you.

Who leads my treatment?

Your care team includes a psychiatric clinician, a guide, and Mindbloom's live support team.

Your clinician will build your personalized treatment plan, and actively monitor your progress to ensure you're getting medicine that's right for you.

Your guide will offer live 1:1 coaching and messaging to help you prepare for treatment and integrate your experiences to enable lasting transformation. Guides also host Group Integration Circles, where you can find connection and healing with fellow Mindbloom clients.

Our support team is standing by to help via SMS, email, and live chat.

How do ketamine tablets work?

Ketamine tablets work through a sublingual delivery system that allows the medication to absorb directly into your bloodstream through the mucous membranes in your mouth. This method bypasses the digestive system, achieving approximately 30% bioavailability—significantly higher than swallowed tablets—while eliminating the need for injections. The rapid dissolve format typically takes 7 minutes to fully administer.

Unlike traditional oral medications that pass through the digestive system, rapid dissolve sublingual ketamine tablets dissolve between the cheeks and gums, allowing the medication to absorb directly into the bloodstream through the mucous membranes in your mouth. This method achieves approximately 30% bioavailability—higher than higher than swallowed tablets (17%-24%) while avoiding the need for injections.⁷'⁸

Sublingual ketamine tablets follow a specific administration protocol:⁹
Place tablets between cheeks and gums (not under the tongue)
Hold for 7 minutes without swallowing
Allow medication to dissolve as it absorbs through oral tissue
After 7 minutes, spit out remaining medication (do not swallow)

This protocol is essential for proper absorption. Effects typically begin within 10-15 minutes, reaching peak intensity within 30-45 minutes. The entire therapeutic experience typically lasts 45-75 minutes.¹⁰

What does clinical evidence show about ketamine tablet efficiency?

The effectiveness of sublingual ketamine tablets has been studied in both controlled trials and real-world clinical settings. In Mindbloom's peer-reviewed research published in the Journal of Affective Disorders, which analyzed outcomes from 1,247 clients with moderate to severe depression and anxiety:⁵

89% reported improvement after completing four sessions
63% achieved a treatment response (≥50% reduction in symptoms)
30% reached remission (scoring below diagnostic threshold on PHQ-9)
62% of participants with suicidal ideation no longer reported suicidal thoughts after treatment

A larger follow-up study of 11,441 Mindbloom clients confirmed sustained benefits:⁶

62% achieved a treatment response in depression or anxiety
84% of participants who initially improved either maintained improvements or recovered with additional treatment
28% achieved full remission after four sessions​​

Note: These results are from open-label, observational studies, which may overestimate treatment effects compared to controlled trials. Individual results vary.

How long does it take to see results?

Some clients see improvements right after their first session. For others, it can take a few more sessions to feel results, but 89% of clients see improvement after 4 sessions. In addition to immediate symptom relief, ketamine can help create new neural connections, facilitate emotional healing, and provide powerful insights for long-lasting, positive lifestyle changes.

Clinical research shows that benefits emerge along different timelines:⁵'²⁵'²⁹

During the session (0-2 hours):
Some people report feeling emotionally lighter or experiencing shifts in perspective during or immediately following their session. The acute therapeutic experience typically lasts 45-75 minutes.

First week after treatment:
Some individuals notice improvements in mood, reduced anxiety, and decreased rumination within 24-72 hours. The potential for rapid-onset effects is one of the key differences between ketamine and traditional antidepressants, though not all patients experience this timeline.

After multiple sessions (1-4 weeks):
With repeated sessions, clients often experience cumulative benefits. Integration practices between sessions can help solidify insights and behavioral changes. Research shows that the majority of improvement occurs within the first four sessions.⁵

While Mindbloom’s clinical research shows that approximately 89% of participants who completed treatment reported improvement in symptoms, ketamine doesn't work for everyone.⁵'⁶

Approximately 11% reported no clinically meaningful improvement, and additional individuals discontinued treatment before completing the initial program.

If you are not progressing in the way you hope to, clinicians can discuss:
• Adjusting the dosing protocol
• Trying a different administration route
• Exploring other evidence-based treatments
• Referral to additional mental health resources

What does ketamine feel like?

The felt experience of ketamine therapy is usually gentle, introspective, and positive. Our clients often report sensations of weightlessness and a dreamlike state. Each session typically lasts 45 minutes-1 hour, and you can resume your daily activities shortly thereafter. 

Your sessions take place at-home, and our clinical study demonstrated that a deeper level of comfort actually leads to improved results. Check out the research here.

The acute effects of a single session typically last 45-75 minutes.¹⁰'²⁹ However, the therapeutic antidepressant effects often persist for days to weeks.²³'⁵⁰

Duration of benefits varies by individual:²³'⁵⁰'⁵¹

• Some people experience sustained improvements for 1-2 weeks after a single session
• With repeated sessions, some maintain benefits for weeks to months
• Some require ongoing maintenance sessions to sustain improvements
• Integration practices between sessions may help extend therapeutic benefits


Here are a few client quotes we love:

“Before Mindbloom, feeling joy required so much work. After my very first session, I was planted in the present moment and immediately felt lighter. It stuck with me and just feels natural now.”
–Katie S.

“I had immediate relief from my anxiety and depression after my very first Mindbloom session. I’m so much more resilient to stress and am able to sit with and process my feelings now. I’m still feeling the benefits after my last session two months ago.”
—Adrienne E.

“After the first session, I started to feel a change in my mood and mindset. Each session thereafter feels like it continues to improve. The cloud of depression has dissipated and my anxiety has been extremely controllable - I feel like when I do get anxious, it comes for a moment and I am able to rationally process and let go.”
—Kaleb E.

Does Mindbloom accept insurance and HSA/FSA?

Currently, most insurance plans don't cover ketamine therapy for depression or anxiety, as it represents off-label use.⁵⁵ However:

• Partial out-of-network insurance reimbursement may be available depending on your plan. This is done by submitting a "superbill," or an itemized receipt provided after the initial virtual consultation.
• At-home programs are typically 60% less expensive than in-clinic IV ketamine (which may cost $400-800 per session)
• Treatment may be HSA/FSA eligible (check with your plan)
• Some people find the cost worthwhile given the potential for rapid relief when other treatments haven't worked

How do different ketamine tablet options compare?

What’s the difference between rapid-dissolve sublingual and extended-release oral tablets?

Not all ketamine tablets work the same way. Understanding the difference helps clarify what you're getting:

Feature Rapid-Dissolve Sublingual Extended-Release Oral
How you take it Hold between cheeks/gums 7 min, then spit Swallow tablet whole
How it absorbs Through oral mucosa Through digestive system
Bioavailability ~30% 17–24%
Time to effects 10–15 minutes 30–60 minutes
Duration 45–75 minutes (controlled) 4–6 hours (gradual)
Dosing control High (discard after 7 min) Lower (full dose absorbed)

Note: This table compares different ketamine administration methods. Mindbloom uses rapid-dissolve sublingual tablets which may offer more control over the therapeutic experience and allows for precise dose adjustments. Individual experiences may vary within each method. 

How do all ketamine delivery methods compare?

Method Bioavailability Onset Duration Setting Relative Cost
Sublingual Tablets ~30% 10–15 min 45–75 min At home $$
Subcutaneous ~75% to 95% 5–15 min 45–75 min Clinic/At Home $$
IV Infusion 100% 1–2 min 40–60 min Clinic $$$$$
Nasal Spray ~45% 5–10 min 45–90 min Clinic $
Intramuscular ~93% 5–15 min 45–120 min Clinic $$$$
Extended-Release Oral 17–24% 30–60 min 4–6 hours Home $$

Can I continue my current antidepressant while using ketamine tablets?

In many cases, yes. Ketamine works through a different mechanism than SSRIs or SNRIs, so they can often be combined safely.⁴⁸ Combination treatment may even enhance outcomes.⁴⁹ However, certain medications may be contraindicated, so it's essential to disclose all current medications during your assessment.

Citations

  1. Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338(6103):68-72. https://doi.org/10.1126/science.1222939
  2. Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017;19(2):93-107. https://doi.org/10.31887/DCNS.2017.19.2/bbandelow
  3. Taylor JH, Landeros-Weisenberger A, Coughlin C, et al. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial. Neuropsychopharmacology. 2018;43(2):325-333. https://doi.org/10.1038/npp.2017.194
  4. Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015;66:509-523. https://doi.org/10.1146/annurev-med-053013-062946
  5. Hull TD, Malgaroli M, Gazzaley A, et al. At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial. J Affect Disord. 2022;314:59-67. https://doi.org/10.1016/j.jad.2022.07.004
  6. Mathai DS, Hull TD, Malgaroli M, et al. At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data. J Affect Disord. 2024;361:198-208. https://doi.org/10.1016/j.jad.2024.05.131
  7. Dore J, Turnipseed B, Dwyer S, et al. Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy. J Psychoactive Drugs. 2019;51(2):189-198. https://doi.org/10.1080/02791072.2019.1587556
  8. Li L, Vlisides PE. Ketamine: 50 Years of Modulating the Mind. Front Hum Neurosci. 2016;10:612. https://doi.org/10.3389/fnhum.2016.00612
  9. Short B, Fong J, Galvez V, Shelker W, Loo CK. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018;5(1):65-78. https://doi.org/10.1016/S2215-0366(17)30272-9
  10. Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol. 2014;77(2):295-301. https://doi.org/10.1111/j.1365-2125.2012.04418.x
  11. Cascade E, Kalali AH, Kennedy SH. Real-World Data on SSRI Antidepressant Side Effects. Psychiatry (Edgmont). 2009;6(2):16-18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719451/
  12. Bystritsky A. Treatment-resistant anxiety disorders. Mol Psychiatry. 2006;11(9):805-814. https://doi.org/10.1038/sj.mp.4001852
  13. Feder A, Rutter SB, Schiller D, Charney DS. The emergence of ketamine as a novel treatment for posttraumatic stress disorder. Adv Pharmacol. 2020;89:261-286. https://doi.org/10.1016/bs.apha.2020.05.004

Disclaimers

IMPORTANT SAFETY INFORMATION
Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary.
Full safety information: www.mindbloom.com/safety-information

OFF-LABEL USE DISCLOSURE
Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.